No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
266 |
4. Check minimum number of eventsNone |
266 |
5. Include endpointsNone |
266 |
6. Filter based on genotype QC (FinnGen only) |
227 |
Control definitions (FinnGen only)
- Control exclude
- L12_PAPULOSQUAMOUS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified papulosquamous disorders
based on the number of shared cases.
Similar with more cases:
- Other papulosquamous disorders
- Papulosquamous disorders
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2302 | 1336 | 944 |
| Only index persons | 1746 | 1046 | 700 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.04 | 0.03 |
| Only index persons | 0.03 | 0.04 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 44.89 | 48.49 | 39.61 |
| Only index persons | 39.20 | 43.78 | 32.35 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 227 | 129 | 98 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.04 |
| Median age at first event (years) | 48.99 | 47.16 | 51.40 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 242
- Matched controls
- 2420
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L44.8
ICD-10 Finland
Other specified papulosquamous disorders
+∞
103.8
92
*
L44.9
ICD-10 Finland
Papulosquamous disorder, unspecified
897.1
70.8
66
*
6970A
ICD-9 Finland
Lichen planus[LICHEN RUBER PLANUS]
+∞
57.6
53
*
D07AC01
ATC
betamethasone; topical
5.5
38.5
150
552
D07XC01
ATC
betamethasone; topical
6.8
34.5
64
121
L30.9
ICD-10 Finland
Dermatitis, unspecified
4.1
22.5
83
273
L40.0
ICD-10 Finland
Psoriasis vulgaris
46.2
20.9
25
6
D07AB02
ATC
hydrocortisone butyrate; topical
3.5
20.0
110
467
E0000UV, ,
ATC
3.2
18.1
138
702
D05AX02
ATC
calcipotriol; topical
45.8
17.6
21
5
D07AD01
ATC
clobetasol; topical
3.8
16.0
59
190
E000001, ,
ATC
3.4
15.5
71
263
D07AC13
ATC
mometasone; topical
3.1
15.2
92
402
D05BB02
ATC
acitretin; oral
34.2
15.0
19
6
D05AX52
ATC
calcipotriol, combinations; topical
12.0
14.4
26
24
L40.5
ICD-10 Finland
Arthropathic psoriasis
+∞
13.7
13
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.0
12.3
39
112
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
+∞
10.5
10
*
R06AE07
ATC
cetirizine; oral
2.4
9.9
120
708
L43.8
ICD-10 Finland
Other lichen planus
57.4
9.7
11
*
69619
ICD-8 Finland
Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)
+∞
9.4
9
*
D07AA02
ATC
hydrocortisone; topical
2.7
8.6
53
226
E000002, ,
ATC
3.0
8.1
39
145
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
4.2
8.1
22
56
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.4
8.1
68
337
E000003, ,
ATC
4.4
7.7
20
49
D07BC01
ATC
betamethasone and antiseptics; topical
3.0
7.4
35
129
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
7.4
101
609
N05BB01
ATC
hydroxyzine; systemic
3.7
7.3
24
70
69698
ICD-8 Finland
Psoriasis and similar disorders, Other disorders
+∞
7.3
7
*
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.2
7.0
80
447
D07AB08
ATC
desonide; topical
2.8
7.0
38
151
S21
ICPC
Skin texture symptom/complaint
2.5
7.0
51
236
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
6.8
83
476
R03AC13
ATC
formoterol; inhalant
3.8
6.5
20
56
L40.8
ICD-10 Finland
Other psoriasis
71.7
6.5
7
*
A10BJ06
ATC
semaglutide; parenteral
4.1
6.4
18
47
69699, ,
ICD-8 Finland
+∞
6.3
6
*
L40.9
ICD-10 Finland
Psoriasis, unspecified
27.5
6.3
8
*
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.9
6.2
31
118
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
23
57
4.35
8.74
1.4
1.4
303.33
297.64
ug/g
0.04
12
36
72
394
2.18
6.63
3.4
3.0
1.08
1.09
e6/l
0.01
32
204
19
52
3.88
6.33
1.3
1.3
—
—
—
0
0
136
956
1.96
6.16
3.0
2.5
75.77
77.01
nmol/l
0.16
126
861
64
359
2.06
5.41
3.9
3.2
3.76
2.89
e6/l
0.22
25
173
89
563
1.92
5.34
3.4
2.1
2.83
2.96
mg/l
0.17
81
490
130
942
1.82
4.98
7.4
4.7
35.60
35.82
g/l
0.18
122
889
155
1187
1.85
4.93
16.0
9.8
4.50
4.09
e9/l
0.86
129
1023
112
780
1.81
4.85
4.4
3.5
—
—
—
0
0
17
52
3.44
4.85
1.1
1.8
229.06
293.00
mu/l
0.84
17
47
95
635
1.82
4.67
3.9
3.3
0.21
0.31
e6/l
0.63
67
461
31
137
2.45
4.62
2.1
1.6
—
—
—
0
0
15
44
3.57
4.54
3.1
3.0
0.50
2.04
index
—
8
25
16
50
3.36
4.42
1.4
1.2
—
—
—
0
0
56
327
1.93
4.15
3.4
2.4
20.39
22.27
%
0.49
56
306
62
376
1.87
4.09
3.4
2.4
11.48
12.88
umol/l
0.84
62
347
122
906
1.70
3.99
2.7
2.1
100.90
95.28
pmol/l
0.44
66
457
26
116
2.39
3.80
1.8
1.6
—
—
—
0
0
145
1140
1.68
3.73
4.8
4.2
0.12
1.30
estimate
0.44
17
233
42
230
2.00
3.72
3.6
3.8
2.06
1.87
mmol/l
0.10
36
189
144
1135
1.66
3.62
4.8
4.2
0.00
6.63
estimate
0.50
17
245
142
1120
1.65
3.52
4.8
4.1
0.00
0.00
estimate
-0.00
17
240
7
10
7.17
3.38
3.4
2.9
920.57
871.40
u/ml
—
7
10
7
11
6.51
3.20
1.7
2.2
—
—
—
0
0
32
169
2.03
3.13
2.7
3.4
116.60
72.51
ng/l
1.30
27
154
135
1075
1.58
3.04
8.8
6.8
1.21
1.21
mmol/l
0.16
124
930
13
46
2.93
2.97
1.2
1.3
—
60.10
—
0
8
48
297
1.77
2.92
9.1
6.8
104.94
104.01
mmol/l
0.68
48
297
9
22
4.21
2.91
1.2
1.3
—
—
—
0
0
95
706
1.57
2.84
3.9
3.2
33.41
31.29
u/l
0.19
90
675
34
191
1.91
2.80
11.7
6.7
1.16
1.25
mmol/l
0.34
34
186
9
23
4.02
2.80
1.2
1.3
—
—
—
0
0
92
683
1.56
2.75
4.8
4.0
6.09
9.33
mg/mmol
0.68
66
429
123
976
1.53
2.70
9.2
6.0
1.21
1.22
mmol/l
0.15
117
903
9
24
3.85
2.70
1.2
1.3
—
—
—
0
0
9
24
3.85
2.70
1.2
1.3
—
—
—
0
0
7
15
4.77
2.61
1.6
1.0
—
—
—
0
0
15
62
2.51
2.59
2.4
3.2
—
—
—
0
0
12
44
2.82
2.58
1.7
1.3
—
—
—
0
0
12
44
2.82
2.58
1.7
1.3
—
—
—
0
0
9
26
3.55
2.51
1.2
1.2
—
—
—
0
0
27
146
1.96
2.49
10.4
8.2
24.03
25.08
mmol/l
0.96
27
146
16
70
2.38
2.47
2.8
3.4
101.19
93.01
%
0.83
16
70
41
255
1.73
2.45
2.4
1.8
—
—
—
0
0
9
27
3.42
2.42
1.2
1.2
—
—
—
0
0
72
519
1.55
2.40
3.9
2.9
377.71
346.83
umol/l
1.41
66
454
13
52
2.59
2.40
1.2
1.3
—
—
—
0
0
49
323
1.65
2.37
2.4
2.3
30.24
29.39
s
0.34
49
313
39
243
1.72
2.32
2.2
1.9
—
—
—
0
0
6
13
4.70
2.28
1.0
1.8
14.85
13.39
umol/l
—
6
13
6
13
4.70
2.28
1.3
1.5
—
—
—
0
0
96
745
1.48
2.24
4.6
3.2
2.35
2.36
mmol/l
0.20
90
679
136
1131
1.46
2.22
8.1
6.7
11.88
11.86
umol/l
0.01
128
1078
7
19
3.76
2.16
1.1
1.2
—
—
—
0
0
69
505
1.51
2.13
5.1
4.2
1.02
1.02
kg/l
0.38
44
340
57
400
1.56
2.12
1.4
1.3
26.95
40.12
iu/ml
0.41
16
121
58
410
1.55
2.09
5.2
3.9
344.69
280.47
ng/l
0.11
48
314
50
343
1.58
2.05
4.0
3.8
0.79
0.82
mmol/l
0.89
45
325
50
346
1.56
1.98
2.6
1.9
—
—
—
0
0
36
230
1.66
1.96
2.2
2.4
—
—
—
0
0
69
513
1.48
1.96
1.8
1.4
0.74
1.83
u/ml
1.22
17
128
5
12
4.23
1.83
1.8
1.3
—
—
—
0
0
5
12
4.23
1.83
1.8
1.3
—
—
—
0
0
33
210
1.66
1.83
3.5
2.6
34.41
32.58
u/l
0.15
27
165
14
67
2.16
1.80
1.3
1.6
—
—
—
0
0
6
18
3.39
1.75
1.3
1.1
—
—
—
0
0
142
1224
1.39
1.71
3.7
3.1
—
—
—
0
0
27
166
1.71
1.70
1.7
1.4
—
—
—
0
0
59
438
1.46
1.67
3.7
2.9
2.44
2.46
mmol/l
0.74
54
388
7
25
2.85
1.66
2.4
4.0
—
—
—
0
0
48
346
1.48
1.58
1.7
1.7
1145.58
1206.87
nmol/l
0.20
38
260
13
64
2.09
1.57
1.4
1.4
—
—
—
0
0
32
211
1.60
1.56
1.9
2.4
—
—
—
0
0
5
15
3.38
1.53
1.2
1.0
—
1.17
—
0
9
64
492
1.41
1.50
3.2
2.5
—
—
—
0
0
214
2004
1.59
1.50
27.1
16.2
24.68
23.99
mg/l
0.11
186
1637
33
222
1.56
1.48
1.4
2.2
330.79
378.29
nmol/l
0.75
28
214
6
22
2.77
1.44
2.8
1.5
—
—
—
0
0
204
1896
1.48
1.43
6.0
5.1
6.32
5.92
mmol/l
2.12
193
1752
81
657
1.35
1.36
2.0
1.7
20.19
20.74
nmol/l
0.13
74
549
62
483
1.38
1.34
2.3
1.9
1.41
1.43
mg/l
0.02
45
378
81
661
1.34
1.30
3.5
2.6
58.71
70.81
u/l
0.58
72
622
5
18
2.81
1.29
1.4
1.2
—
—
—
0
0
5
18
2.81
1.29
1.0
1.0
—
—
—
0
0
9
44
2.09
1.28
1.4
1.3
—
—
—
0
0
169
1534
1.34
1.26
6.8
4.3
13.08
11.77
mm/h
0.62
160
1425
200
1864
1.42
1.26
23.3
15.9
84.47
80.77
ml/min/173m2
1.43
183
1730
8
36
2.26
1.25
1.3
1.2
97.82
22.95
u/l
—
8
30
9
45
2.04
1.24
1.6
1.4
—
—
—
0
0
5
19
2.66
1.22
1.2
1.0
—
—
—
0
0
47
355
1.40
1.22
1.4
1.4
1.13
10.10
u/ml
2.72
14
144
214
2023
1.50
1.21
28.0
19.1
139.55
139.75
mmol/l
0.55
209
1991
34
242
1.47
1.20
11.4
6.9
-0.56
1.08
mmol/l
1.41
27
203
20
126
1.64
1.19
1.2
1.2
101.53
130.30
u/ml
—
7
45
214
2026
1.49
1.16
28.3
19.1
3.96
3.97
mmol/l
0.18
209
1991
17
104
1.68
1.12
1.9
1.5
0.42
0.26
mg/l
—
6
40
7
31
2.29
1.11
1.1
1.3
—
—
—
0
0
55
434
1.35
1.10
1.8
1.6
—
—
—
0
0
220
2099
1.53
1.09
31.5
21.0
75.80
76.38
umol/l
0.09
215
2080
5
21
2.41
1.09
1.4
1.0
—
—
—
0
0
13
74
1.80
1.09
4.9
4.2
24.58
24.70
mmol/l
0.06
13
69
197
1846
1.36
1.07
9.0
6.4
41.32
39.22
mmol/mol
1.78
190
1738
12
67
1.83
1.06
1.7
1.2
—
—
—
0
0
19
124
1.58
1.00
4.9
3.4
1.20
1.96
mmol/l
0.42
14
88
172
1588
1.29
0.99
5.0
4.3
14.92
14.85
pmol/l
0.16
162
1446
198
1866
1.34
0.95
6.5
5.4
1.93
1.92
mu/l
0.06
187
1720
78
660
1.27
0.93
3.6
3.2
1192.96
1471.27
ng/l
0.29
70
563
23
160
1.48
0.93
2.5
2.6
76.23
63.95
ml/min/173m2
0.68
13
63
217
2077
1.43
0.92
17.8
11.9
27.13
24.91
u/l
1.31
212
2029
21
144
1.50
0.91
6.0
3.3
5.32
5.09
kpa
0.75
21
139
19
128
1.53
0.89
1.3
1.4
—
30.05
—
0
12
6
30
2.02
0.87
1.0
1.6
—
—
—
0
0
6
32
1.90
0.82
1.2
1.1
—
—
—
0
0
10
58
1.76
0.81
1.4
1.9
—
—
—
0
0
16
109
1.50
0.73
1.3
1.3
—
—
—
0
0
56
473
1.24
0.68
4.2
4.7
26.03
21.45
%
0.76
23
233
43
355
1.26
0.63
3.0
3.1
0.72
0.77
ug/l
0.13
33
230
108
981
1.18
0.61
3.3
2.8
—
—
estimate
—
0
0
8
51
1.59
0.61
2.0
1.7
72.23
58.64
ug/l
—
8
41
9
62
1.47
0.53
1.2
1.1
—
—
—
0
0
9
63
1.44
0.53
1.2
1.1
—
—
—
0
0
199
1916
1.22
0.52
5.9
5.2
4.45
4.61
mmol/l
1.24
188
1776
222
2164
1.31
0.51
38.2
24.4
249.46
249.46
e9/l
0.00
214
2130
222
2165
1.31
0.50
38.2
24.3
90.90
91.00
fl
0.12
216
2151
222
2166
1.30
0.48
39.8
24.6
40.00
40.18
%
0.19
216
2150
222
2166
1.30
0.48
38.2
24.3
4.53
4.46
e12/l
1.05
214
2124
13
174
0.73
0.45
3.8
4.0
1.23
1.23
mmol/l
0.00
13
153
222
2169
1.28
0.45
38.4
24.5
134.26
134.36
g/l
0.03
217
2151
94
864
1.14
0.43
4.6
4.0
0.20
0.00
estimate
0.46
15
200
8
56
1.44
0.43
1.4
1.8
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
11.00
—
0
16
0
16
0.00
0.41
0.0
5.1
—
90.29
—
0
16
9
66
1.38
0.39
3.2
1.8
—
—
—
0
0
9
71
1.28
0.36
3.6
2.1
—
—
—
0
0
6
43
1.41
0.35
1.2
1.2
—
—
—
0
0
143
1364
1.12
0.34
4.6
3.2
59.27
43.43
u/l
1.20
135
1282
14
111
1.28
0.30
1.9
2.0
—
—
—
0
0
7
56
1.26
0.29
1.9
1.4
—
—
—
0
0
13
103
1.28
0.29
1.2
1.2
—
—
—
0
0
15
122
1.24
0.27
3.0
3.0
0.55
0.64
%
0.87
15
122
15
125
1.21
0.23
3.0
3.0
1.14
1.24
%
0.13
15
125
5
41
1.22
0.22
1.0
2.0
—
—
—
0
0
36
326
1.12
0.21
1.6
1.4
—
—
—
0
0
5
42
1.19
0.21
1.0
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
301.83
—
0
6
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
211.63
—
0
14
0
14
0.00
0.20
0.0
1.3
—
334.48
—
0
14
0
14
0.00
0.20
0.0
1.3
—
58.41
—
0
14
6
52
1.16
0.19
1.0
1.3
—
—
—
0
0
25
223
1.14
0.19
7.3
7.5
—
—
—
0
0
194
1908
1.08
0.16
5.5
5.0
1.36
1.48
mmol/l
3.35
185
1764
185
1819
1.07
0.14
4.9
4.3
1.37
1.25
mmol/l
1.47
174
1671
67
644
1.06
0.11
5.6
4.2
0.00
0.00
estimate
-0.00
15
222
6
55
1.09
0.09
2.2
1.5
—
—
—
0
0
197
1950
1.06
0.09
7.2
5.9
2.54
2.68
mmol/l
1.38
188
1809
5
60
0.83
0.08
1.0
1.2
1.45
1.59
g/l
—
5
60
7
67
1.05
0.08
1.6
1.3
—
—
—
0
0
80
820
0.96
0.07
4.8
4.1
27.21
42.37
ng/l
1.28
54
591
17
181
0.93
0.05
2.1
2.0
3.55
3.23
ratio
0.52
11
146
18
170
1.06
0.04
2.8
2.4
8.45
5.91
ug/l
0.22
18
150
20
209
0.95
0.03
3.3
3.5
—
—
—
0
0
11
117
0.94
0.02
1.0
1.1
—
—
—
0
0
13
137
0.95
0.01
1.3
1.8
3.72
3.40
mmol/l
—
6
102
14
138
1.02
0.00
2.6
2.0
—
—
—
0
0
63
634
0.99
0.00
3.7
3.5
0.00
0.14
estimate
0.52
15
187
85
854
0.99
0.00
2.2
2.0
1.39
1.32
mmol/l
0.33
78
722
10
104
0.96
0.00
3.1
3.2
184.30
688.05
u/ml
—
10
93
0
5
0.00
0.00
0.0
1.0
—
30.66
—
0
5
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
61
0.98
-0.00
1.0
1.2
0.93
0.87
g/l
—
6
61
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
68
0.88
-0.00
1.3
1.1
—
5.97
—
0
6
7
71
0.99
-0.00
1.7
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
-0.00
1.3
2.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.4
—
—
—
0
0
5
57
0.87
-0.00
1.2
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_PAPULOSQUONAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_PAPULOSQUONAS | 1.667 [1.17, 2.38] | 0.005 |
| Birth year | 0.992 [0.98, 1.0] | 0.063 |
During the follow-up period (1.1.1998 — 31.12.2019), 87 out of 566 females with L12_PAPULOSQUONAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_PAPULOSQUONAS | 1.932 [1.32, 2.84] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.008 |
During the follow-up period (1.1.1998 — 31.12.2019), 88 out of 428 males with L12_PAPULOSQUONAS died.
Mortality risk
Mortality risk for people of age
years, who have L12_PAPULOSQUONAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.115% | 0.391% |
| 5 | 0.836% | 2.163% |
| 10 | 2.197% | 5.375% |
| 15 | 4.318% | 10.143% |
| 20 | 7.431% | 16.83% |
Relationships between endpoints
↥Index endpoint: L12_PAPULOSQUONAS – Other and unspecified papulosquamous disorders
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data